U.S. Rep. Mary Bono Mack (D-Calif.) has introduced a bill that would call on FDA to require pharmaceutical companies to use tamper-resistant formulas for new opiate-based drugs in an effort to curb prescription drug misuse. Some pharmaceutical firms likely will oppose the legislation because it would increase manufacturing costs.